Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding do

来源 :定量生物学(英文版) | 被引量 : 0次 | 上传用户:mmg5fc1cc
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:A novel coronavirus(the SARS-CoV-2)has been identified in January 2020 as the causal pathogen for COVID-19,a pandemic started near the end of 2019.The Angiotensin converting enzyme 2 protein(ACE2)utilized by the SARS-CoV as a receptor was found to facilitate the infection of SARS-CoV-2,initiated by the binding of the spike protein to human ACE2.Methods:Using homology modeling and molecular dynamics(MD)simulation methods,we report here the detailed structure and dynamics of the ACE2 in complex with the receptor binding domain(RBD)of the SARS-CoV-2 spike protein.Results:The predicted model is highly consistent with the experimentally determined structures,validating the homology modeling results.Besides the binding interface reported in the crystal structures,novel binding poses are revealed from all-atom MD simulations.The simulation data are used to identify critical residues at the complex interface and provide more details about the interactions between the SARS-CoV-2 RBD and human ACE2.Conclusion:Simulations reveal that RBD binds to both open and closed state of ACE2.Two human ACE2 mutants and rat ACE2 are modeled to study the mutation effects on RBD binding to ACE2.The simulations show that the N-terminal helix and the K353 are very important for the tight binding of the complex,the mutants are found to alter the binding modes of the CoV2-RBD to ACE2.
其他文献
以紫杉醇及紫杉醇注射液为例,根据《化学药物杂质研究的技术指导原则》,并参考《中国药典》《美国药典》《欧洲药典》《英国药典》,探讨单一成分药物有关物质质量控制研究要
Background:Now the coronavirus disease 2019(COVID-19)epidemic becomes a global phenomenon and its development concerns billions of peoples'lives.The development
Hepatic resection represents the first-line treatment for patients with resectable hepatocellular carcinoma (HCC).However,the 5-year recurrence rates of HCC aft